Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS2R31 | P59538 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.44 |
| ▸ | PNLIP | P16233 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Agathic Acid SCHEMBL30436331 | 1.00 | TAS2R31 (0.64) | TAS2R31POLBMAPTPTPN1CYP2C9 | |
| Agathic Acid SCHEMBL29358171 | 1.00 | TAS2R31 (0.64) | TAS2R31POLBMAPTPTPN1CYP2C9 | |
| SCHEMBL30436964 | 0.90 | POLB (0.58) | TAS2R31POLBMAPTPTPN1CYP2C9 | |
| Isocupressic Acid SCHEMBL13532265 | 0.89 | POLB (0.66) | TAS2R31POLBMAPTPTPN1CYP2C9 | |
| Isocupressic Acid SCHEMBL19139984 | 0.89 | POLB (0.66) | TAS2R31POLBMAPTPTPN1CYP2C9 | |
| Copalic Acid SCHEMBL25221800 | 0.89 | TAS2R31 (0.66) | TAS2R31POLBMAPTPTPN1LMNA | |
| Copalic Acid SCHEMBL29481956 | 0.89 | TAS2R31 (0.66) | TAS2R31POLBMAPTPTPN1LMNA | |
| Copalic Acid SCHEMBL34460866 | 0.89 | TAS2R31 (0.66) | TAS2R31POLBMAPTPTPN1LMNA | |
| SCHEMBL15214261 | 0.88 | POLB (0.64) | TAS2R31POLBMAPTPTPN1CYP2C9 | |
| SCHEMBL21914841 | 0.88 | TAS2R31 (0.63) | TAS2R31POLBMAPTPTPN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624263-B2 | Dimensionally stable, wipe-on, modified-polyether-polyurethane-based adhesive compound | HENKEL AG & CO. KGAA (DE) | 2026-05-12 | — | — | US | disclosed |
| US-12577446-B2 | Dimensionally stable, wipe-on, semi-crystalline-polyester-based adhesive compound | HENKEL AG & CO. KGAA (DE) | 2026-03-17 | — | — | US | disclosed |
| US-20250064716-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2025-02-27 | — | — | US | disclosed |
| EP-4452200-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2024-10-30 | — | — | EP | disclosed |
| WO-2023118430-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2023-06-29 | — | — | WO | disclosed |
| EP-4077449-A1 | DIMENSIONALLY STABLE, WIPE-ON, SEMI-CRYSTALLINE POLYESTER-BASED ADHESIVE COMPOUND | Henkel AG & Co. KGaA (DE) | 2022-10-26 | — | — | EP | disclosed |
| EP-4077448-A1 | DIMENSIONALLY STABLE, WIPE-ON, MODIFIED POLYETHER-POLYURETHANE-BASED ADHESIVE COMPOUND | Henkel AG & Co. KGaA (DE) | 2022-10-26 | — | — | EP | disclosed |
| US-20220306918-A1 | DIMENSIONALLY STABLE, WIPE-ON, MODIFIED-POLYETHER-POLYURETHANE-BASED ADHESIVE COMPOUND | HENKEL AG & CO. KGAA (DE) | 2022-09-29 | — | — | US | disclosed |
| US-20220306919-A1 | DIMENSIONALLY STABLE, WIPE-ON, SEMI-CRYSTALLINE-POLYESTER-BASED ADHESIVE COMPOUND | HENKEL AG & CO. KGAA (DE) | 2022-09-29 | — | — | US | disclosed |
| CN-114846048-A | Dimensionally stable, spreadable adhesive mass based on modified polyether polyurethanes | 汉高股份有限及两合公司 | 2022-08-02 | — | — | CN | disclosed |
| CN-114829439-A | Dimensionally stable, spreadable adhesive mass based on semicrystalline polyesters | 汉高股份有限及两合公司 | 2022-07-29 | — | — | CN | disclosed |
| US-11311591-B2 | Use of copaifera oleoresin in pathologies of the prostate | PIERRE FABRE MEDICAMENT (FR) | 2022-04-26 | — | — | US | disclosed |
| US-10925915-B2 | Use of a Copaifera extract to combat alopecia and seborrhea | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2021-02-23 | — | — | US | disclosed |
| US-20200093879-A1 | USE OF COPAIFERA OLEORESIN IN PATHOLOGIES OF THE PROSTATE | PIERRE FABRE MEDICAMENT (FR) | 2020-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11311591-B2 | Use of copaifera oleoresin in pathologies of the prostate | ACP3, BPHL, CYP17A1 | TAS2R31 4363/4885POLB 2539/4885MAPT 1210/4885 |
| US-10925915-B2 | Use of a Copaifera extract to combat alopecia and seborrhea | CUTA, CYP17A1, CYP51A1 | TAS2R31 2510/4885POLB 1736/4885MAPT 1566/4885 |
| US-12577446-B2 | Dimensionally stable, wipe-on, semi-crystalline-polyester-based adhesive compound | MACF1, WAPL, ICAM1 | TAS2R31 3061/4885POLB 2470/4885MAPT 58/4885 |
| US-20200093879-A1 | USE OF COPAIFERA OLEORESIN IN PATHOLOGIES OF THE PROSTATE | ACP3, BPHL, CYP17A1 | TAS2R31 4363/4885POLB 2539/4885MAPT 1210/4885 |
| US-12624263-B2 | Dimensionally stable, wipe-on, modified-polyether-polyurethane-based adhesive compound | MACF1, ICAM1, ILK | TAS2R31 2333/4885POLB 3738/4885MAPT 51/4885 |
| US-20250064716-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | KRT18, CUTA, RARA | TAS2R31 850/4885POLB 1242/4885MAPT 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.